FILE PHOTO: Vials labelled"Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERSPIX: A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
The phase-three trial was carried out mostly on participants “at high risk of progression to severe Covid-19”, AstraZeneca added in a statement.“Despite the success of vaccines, many individuals such as older adults, individuals with co-morbidities and those who are immunocompromised, remain at risk for poor outcomes from severe Covid-19,“ said trial lead Hugh Montgomery, professor of intensive care medicine at University College London.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.